InvestorsHub Logo
Followers 74
Posts 16360
Boards Moderated 3
Alias Born 04/24/2000

Re: micham2012 post# 1715

Thursday, 02/08/2018 9:20:48 AM

Thursday, February 08, 2018 9:20:48 AM

Post# of 2104
Conatus Pharmaceuticals (NASDAQ:CNAT) initiated with Buy rating and $20 (297% upside) price target at ROTH Capital.

Theo ;-)